This info came out this week. The trial started last year. cdx-1135 is one of 9 potential blockbusters Celldex
owns free and clear. Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
This study is currently recruiting participants.
Verified February 2013 by Celldex Therapeutics
Information provided by (Responsible Party):
Celldex TherapeuticsClinicalTrials.gov Identifier:
First received: January 29, 2013
Last updated: February 12, 2013
Last verified: February 2013
History of Changes
I would always expect a pullback you have to with biotech and with the share count so low it can be quick but as you know I am well long this company has an easy 15 or 20 in it in the next few months to year but I would watch for harsh funds or hedge to price control the stock you have to in todays world the one percent can control the price of this company very easily. I did notice chart breaks over the last few days in the morning but nothing major I think tomorrow will be a very telling day on price strength because I would not think they let it go through 9. 7.63, 9 and 11 were short periods 3 years back or so. Have you bought all you want or are you buying and selling? I am loading the back end in 2015 with options all the 5 dollar options in 2015 are me.